Kah Leng Fong

Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 7-year follow-up of the phase 3, double-blind, randomised controlled VIVIANE study

Cosette M. Wheeler, S. Rachel Skinner, Maria Rowena Del Rosario‐Raymundo et al. · The Lancet Infectious Diseases · 2016 · 187 citations

Vaccination, Vaccine Safety, Vaccinology +12

Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 4-year interim follow-up of the phase 3, double-blind, randomised controlled VIVIANE study

S. Rachel Skinner, Anne Szarewski, Barbara Romanowski et al. · The Lancet · 2014 · 180 citations

Vaccination, Vaccine Safety, Vaccinology +13

The Natural History of Vulvar Intraepithelial Neoplasia, Differentiated Type: Evidence for Progression and Diagnostic Challenges

Susan M. Bigby, Lois Eva, Kah Leng Fong et al. · International Journal of Gynecological Pathology · 2016 · 85 citations

Squamous Cell Carcinoma, Vulvar Intraepithelial Neoplasia, Gynecology +21

Trends in HPV-dependent and HPV-independent vulvar cancers: The changing face of vulvar squamous cell carcinoma

Lois Eva, Lynn Sadler, Kah Leng Fong et al. · Gynecologic Oncology · 2020 · 40 citations

Vulvar Diseases, Cervical Cancer, Squamous Cell Carcinoma +9

HPV-independent and HPV-associated vulvar squamous cell carcinoma: two different cancers

Lois Eva, Lynn Sadler, John Thompson et al. · International Journal of Gynecological Cancer · 2022 · 25 citations